2.50
Hdl Handle:
http://hdl.handle.net/10146/30295
Title:
Bulky DNA adduct formation and risk of bladder cancer.
Authors:
Castano-Vinyals, Gemma; Talaska, Glenn; Rothman, Nathaniel; Alguacil, Juan; Garcia-Closas, Montserrat; Dosemeci, Mustafa; Cantor, Kenneth P.; Malats, Nuria; Real, Francisco X.; Silverman, Debra; Serra, Consol; Carrato, Alfredo; Tardon, Adonina; Garcia-Closas, Reina; Kogevinas, Manolis; Vermeulen, Roel
Abstract:
Exposure to polycyclic aromatic hydrocarbons (PAHs) has been associated with risk of bladder cancer and with increased bulky DNA adduct levels in several studies, mainly in smokers. We investigated the relation between bulky PAH-DNA adducts in peripheral blood mononuclear cells and bladder cancer in nonsmoking subjects from a large hospital-based case-control study in Spain. Additionally, we examined the association between DNA adduct formation and several air pollution proxies. The study comprised 76 nonsmoking cases and 76 individually matched controls by sex, region of residence, age, and smoking status (never, former). To maximize the relevance of the DNA adduct measurement as a proxy of PAH exposure, subjects selected had not changed residence, occupation, and major lifestyle factors during the last 10 years. Bulky DNA adducts were measured using the (32)P-postlabeling technique, nuclease P1 treatment. The percentage of detectable adducts was higher in controls (41%) than in cases (32%) with an odds ratio of 0.75 (95% confidence interval, 0.36-1.58). In an analysis limited to controls, a higher percentage of DNA adducts was found among those whose last residence was in a big city (50%) compared with those living in villages (19%; P = 0.04). No consistent associations were found for other markers of air pollution. In this study, among nonsmokers with stable environmental and lifestyle factors, bulky DNA adducts were not associated with bladder cancer risk. Results do not support an association of bladder cancer risk with low-level exposure to PAHs as measured through the formation of bulky DNA adducts in peripheral mononuclear cells.
Citation:
Cancer Epidemiol. Biomarkers Prev. 2007, 16 (10):2155-2159
Journal:
Cancer Epidemiology, Biomarkers & Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Issue Date:
Oct-2007
URI:
http://hdl.handle.net/10146/30295
DOI:
10.1158/1055-9965.EPI-07-0184
PubMed ID:
17932365
Additional Links:
http://cebp.aacrjournals.org/cgi/content/full/16/10/2155
Type:
Article
Language:
en
ISSN:
1055-9965
Appears in Collections:
Articles

Full metadata record

DC FieldValue Language
dc.contributor.authorCastano-Vinyals, Gemma-
dc.contributor.authorTalaska, Glenn-
dc.contributor.authorRothman, Nathaniel-
dc.contributor.authorAlguacil, Juan-
dc.contributor.authorGarcia-Closas, Montserrat-
dc.contributor.authorDosemeci, Mustafa-
dc.contributor.authorCantor, Kenneth P.-
dc.contributor.authorMalats, Nuria-
dc.contributor.authorReal, Francisco X.-
dc.contributor.authorSilverman, Debra-
dc.contributor.authorSerra, Consol-
dc.contributor.authorCarrato, Alfredo-
dc.contributor.authorTardon, Adonina-
dc.contributor.authorGarcia-Closas, Reina-
dc.contributor.authorKogevinas, Manolis-
dc.contributor.authorVermeulen, Roel-
dc.date.accessioned2008-06-23T11:18:45Z-
dc.date.available2008-06-23T11:18:45Z-
dc.date.issued2007-10-
dc.identifier.citationCancer Epidemiol. Biomarkers Prev. 2007, 16 (10):2155-2159en
dc.identifier.issn1055-9965-
dc.identifier.pmid17932365-
dc.identifier.doi10.1158/1055-9965.EPI-07-0184-
dc.identifier.urihttp://hdl.handle.net/10146/30295-
dc.description.abstractExposure to polycyclic aromatic hydrocarbons (PAHs) has been associated with risk of bladder cancer and with increased bulky DNA adduct levels in several studies, mainly in smokers. We investigated the relation between bulky PAH-DNA adducts in peripheral blood mononuclear cells and bladder cancer in nonsmoking subjects from a large hospital-based case-control study in Spain. Additionally, we examined the association between DNA adduct formation and several air pollution proxies. The study comprised 76 nonsmoking cases and 76 individually matched controls by sex, region of residence, age, and smoking status (never, former). To maximize the relevance of the DNA adduct measurement as a proxy of PAH exposure, subjects selected had not changed residence, occupation, and major lifestyle factors during the last 10 years. Bulky DNA adducts were measured using the (32)P-postlabeling technique, nuclease P1 treatment. The percentage of detectable adducts was higher in controls (41%) than in cases (32%) with an odds ratio of 0.75 (95% confidence interval, 0.36-1.58). In an analysis limited to controls, a higher percentage of DNA adducts was found among those whose last residence was in a big city (50%) compared with those living in villages (19%; P = 0.04). No consistent associations were found for other markers of air pollution. In this study, among nonsmokers with stable environmental and lifestyle factors, bulky DNA adducts were not associated with bladder cancer risk. Results do not support an association of bladder cancer risk with low-level exposure to PAHs as measured through the formation of bulky DNA adducts in peripheral mononuclear cells.en
dc.language.isoenen
dc.relation.urlhttp://cebp.aacrjournals.org/cgi/content/full/16/10/2155en
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAir Pollution-
dc.subject.meshCase-Control Studies-
dc.subject.meshCross-Sectional Studies-
dc.subject.meshDNA Adducts-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPolycyclic Hydrocarbons, Aromatic-
dc.subject.meshRisk Factors-
dc.subject.meshRural Population-
dc.subject.meshSmoking-
dc.subject.meshSmoking Cessation-
dc.subject.meshSpain-
dc.subject.meshUrban Population-
dc.subject.meshUrinary Bladder Neoplasms-
dc.titleBulky DNA adduct formation and risk of bladder cancer.en
dc.typeArticleen
dc.identifier.journalCancer Epidemiology, Biomarkers & Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncologyen

Related articles on PubMed

All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.